About This Fund
Epsicap Nano (formerly Epsilon 360°) is a French Société Civile de Placement Immobilier (SCPI) managed by Epsicap REIM (formerly Epsilon Capital), an Autorité des Marchés Financiers (AMF)-registered portfolio management company headquartered in Bordeaux, France. The fund received its AMF visa in September 2021, making it France's first SCPI exclusively dedicated to small-cap commercial real estate — tertiary assets including offices, retail premises, and light-industrial spaces with individual asset values typically between €1 million and €10 million, below the threshold attracting institutional competition. The fund's capitalisation reached €188 million as of 31 December 2025 under its open-ended, variable-capital structure.
Epsicap Nano pursues an income-oriented, diversified strategy targeting commercial assets overlooked by larger institutional buyers. The fund delivered a 6.08% distribution rate in 2022, rising to 6.55% in 2024, with a stated target of 7.00%+ distribution yield and total returns above 8.25% for 2025. As of September 2025, non-French European assets represented 26% of the portfolio, with a roadmap to reach 40% by end-2025 and 50% by mid-2026. Active international markets include Spain, reflecting the fund's accelerating Pan-European diversification beyond its French core. The fund renamed itself from Epsilon 360° to Epsicap Nano in June 2025, aligning with the broader rebranding of the management company from Epsilon Capital to Epsicap REIM.
The fund's differentiation lies in competing in a market segment where institutional capital is structurally underrepresented: assets priced between €1 million and €10 million attract fewer competing bidders than prime Parisian commercial real estate, allowing Epsicap Nano to capture yield premiums unavailable in the core commercial property market. The variable-capital SCPI structure allows continuous unit issuance and redemption subject to queue management, providing a level of liquidity uncommon in traditional closed-end real estate vehicles.